Le Lézard
Classified in: Science and technology
Subject: Business Update

BrainChip's Latest US Patent Award Extends Intellectual Property Strength and its Leadership in Edge Learning


BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world's first commercial producer of ultra-low power, fully digital, event-based, neuromorphic AI IP, was awarded its latest US patent, further strengthening the company's neuromorphic technology portfolio and demonstrating the company's competitive research strength.

Patent No. US 11,704,549, "Event-Based Classification of Features in a Reconfigurable and Temporally Coded Convolutional Spiking Neural Network," protects BrainChip's neuromorphic processor, which is configured to perform convolutions on digital input data that has been converted into spikes. Additionally, the patent safeguards the feature of reconfigurability in a neural processor, which enables the development of multipurpose and cost-effective hardware designs, such as Akidatm.

"Patents are hallmarks of a company's innovation, domain expertise and prowess in pushing the bounds of technology," said Nandan Nayampally, Chief Marketing Officer at BrainChip. "This latest award from the USPTO not only protects our unique approach to neuromorphic computing and learning, but further enhances the commercial value of our IP. We continually strive to extend our portfolio of assets to ensure that customers and partners gain competitive advantages through our technology."

BrainChip's portfolio now comprises seventeen issued patents (12 US, 3 Australian, 1 European and 1 Chinese). An additional thirty patent applications remain pending in the US, Europe, Australia, Canada, Japan, Korea, India, Brazil, Russia, Mexico, and Israel.

About BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY)

BrainChip is the worldwide leader in edge AI on-chip processing and learning. The company's first-to-market, fully digital, event-based AI processor, AkidaTM, uses neuromorphic principles to mimic the human brain, analyzing only essential sensor inputs at the point of acquisition, processing data with unparalleled efficiency, precision, and economy of energy. Akida uniquely enables edge learning local to the chip, independent of the cloud, dramatically reducing latency while improving privacy and data security. Akida Neural processor IP, which can be integrated into SoCs on any process technology, has shown substantial benefits on today's workloads and networks, and offers a platform for developers to create, tune and run their models using standard AI workflows like Tensorflow/Keras. In enabling effective edge compute to be universally deployable across real world applications such as connected cars, consumer electronics, and industrial IoT, BrainChip is proving that on-chip AI, close to the sensor, is the future, for its customers' products, as well as the planet. Explore the benefits of Essential AI at www.brainchip.com.

Follow BrainChip on Twitter: https://www.twitter.com/BrainChip_inc
Follow BrainChip on LinkedIn: https://www.linkedin.com/company/7792006


These press releases may also interest you

at 04:09
China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...

at 04:05
H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $64 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to acquire CGH Group S.A. ("CGH" or the "Company"), a...

at 03:55
The International Nut and Dried Fruit Council (INC), conducted an extensive study on Latin America's Gen Z dietary...

at 03:44
Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, is publishing its interim report for January-June on Friday 19 July 2024 at 07.30 CET.  Alan Mamedi, CEO and Odd Bolin, CFO presents the report and...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:09
China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...



News published on and distributed by: